Yahoo Finance • 28 days ago
Investors considering a purchase of 10x Genomics Inc (Symbol: TXG) shares, but tentative about paying the going market price of $13.27/share, might benefit from considering selling puts among the alternative strategies at their disposal.... Full story
Yahoo Finance • last month
Cathie Wood’s ARK ETF published their daily trades for Monday, August 18th, 2025, showcasing a continued focus on the biotech sector while reducing exposure in defense. The largest trade of the day was the purchase of 170,471 shares of Gen... Full story
Yahoo Finance • 2 months ago
Cathie Wood’s ARK ETFs have once again made significant trades on Tuesday, 12 August 2025, with a major focus on tech and biotech stocks. The most substantial trade of the day was the purchase of 738,367 shares of Trade Desk Inc (NASDAQ:... Full story
Yahoo Finance • 2 months ago
In trading on Friday, shares of 10x Genomics Inc (Symbol: TXG) crossed below their 200 day moving average of $12.22, changing hands as low as $11.88 per share. 10x Genomics Inc shares are currently trading down about 3.2% on the day. The... Full story
Yahoo Finance • 2 months ago
10X Genomics Inc-Class A (NASDAQ:TXG [https://www.chartmill.com/stock/quote/TXG/profile]) reported its second-quarter 2025 financial results, delivering a significant earnings surprise and revenue beat, which has triggered a positive after... Full story
Yahoo Finance • 2 months ago
What Happened? A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending shockwaves across the health... Full story
Yahoo Finance • 2 months ago
(All amounts expressed in Canadian dollars unless otherwise stated) TORONTO, July 28, 2025 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (“Torex”, the “Company”) (TSX:TXG) (OTCQX:TORXF) and Prime Mining Corp. (“Prime Mining”) (TSX: PRYM... Full story
Yahoo Finance • 3 months ago
What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story
Yahoo Finance • 3 months ago
Investing.com - Canaccord Genuity has reiterated its Buy rating and $15.00 price target on 10X Genomics (NASDAQ:TXG), citing the company’s potential to benefit from large-scale single cell studies and artificial intelligence applications.... Full story
Yahoo Finance • 3 months ago
[Wide Angle Shot of a Clean and Organized Modern Laboratory] Tom Werner * Several life sciences tools companies closed noticably higher Wednesday following a report that the NIH has issued a memo not to cancel funding for any more resea... Full story
Yahoo Finance • 3 months ago
Investing.com – Canada stocks were lower after the close on Friday, as losses in the Clean Technology, IT and Materials sectors led shares lower. At the close in Toronto, the S&P/TSX Composite declined 0.03%. The best performers of the s... Full story
Yahoo Finance • 3 months ago
What Happened? A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports pointed to easing tensions between Israel and Iran. The Wall Street Journal said senior Iranian... Full story
Yahoo Finance • 4 months ago
June 3 - Cathie Wood's Ark Invest sold 1,594 shares of Tesla Inc (NASDAQ:TSLA) through its ARK Innovation ETF (ARKK), offloading a position worth $546,247, according to a Monday disclosure. The move comes as Tesla faces growing pressure f... Full story
Yahoo Finance • 8 months ago
Why 10x Genomics (TXG) Shares Are Falling Today What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 8.5% in the pre-market session after the company reported disappointing fourth-quarter results: its EPS missed signif... Full story
Yahoo Finance • last year
Insight into ARK Investment Management's Q2 2024 Moves Cathie Wood, the visionary behind ARK Investment Management, recently disclosed her 13F filings for the second quarter of 2024. With over four decades of experience in investment mana... Full story
Yahoo Finance • 2 years ago
In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there's one t... Full story
Yahoo Finance • 2 years ago
PLEASANTON, Calif., Dec. 7, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a collaboration with theNIH Intramural Center for Alzheimer's and Related Dementias (NIH CARD)... Full story
Yahoo Finance • 2 years ago
Participants Cassie Corneau; Manager of IR and Strategic Finance; 10x Genomics, Inc. Justin J. McAnear; CFO; 10x Genomics, Inc. Serge Saxonov; Co-Founder, CEO & Director; 10x Genomics, Inc. Daniel Anthony Arias; MD & Senior Analyst; St... Full story
Yahoo Finance • 2 years ago
PLEASANTON, Calif., Nov. 1, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the Stephens 25th An... Full story